LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Intellirod Spine: $1 Million for Wireless Sensors
Spine

Intellirod Spine: $1 Million for Wireless Sensors

August 1, 2016 2 min read Premium comments

Advertisement

Intellirod Spine: $1 Million for Wireless Sensors
LOADPRO Intraoperative Rod Strain Sensor / Courtesy of Intellirod Spine
Secondary

Curious about the strain being put on that spine implant? So was Intellirod Spine. The company has just announced that it has raised more than $1 million in equity financing from new and existing investors to do that and more.

As indicated in the July 26, 2016 news release, “Funds will be used to reach key milestones toward the commercialization of the company’s sensor technologies and related lumbar fusion implants.”

According to Intellirod CEO Ric Navarro, “The LOADPRO gives a surgeon new and important information for improving surgical technique. The device becomes an adjunct to the surgeon’s tactile feel for avoiding excessive implant loading.”

Rolando M. Puno, M.D. of Louisville, Kentucky, stated, “With LOADPRO, for the first time, spine surgeons will have an accurate tool to measure and determine the amount of force being applied to the rod implant as spinal deformity is being corrected. Knowing the amount of applied strain will allow spine surgeons to adjust their surgical techniques to achieve the best possible correction of deformity. Furthermore, spine surgeons will be able to avoid the risk of inadvertently applying excessive strain causing fixation failure and/or loss of correction.”

Spine surgeon Michael Steinmetz, M.D. further explained, “The information gained from LOADPRO may allow the surgeon, for the first time, to understand the forces applied to spinal constructs when performing deformity surgery. This information can lead to improved surgical results and patient outcomes.”

Says the news release, “In addition, the company has completed its pre-clinical testing in support of an FDA application for ACCUVISTA, its implantable version of the product. The ACCUVISTA sensor monitors post-operative strain in rods in degenerative disc disease fusion patients, and the company is bullish on its new application for ACCUVISTA in children with scoliosis.”

Asked for detail on the “key milestones” they are aiming for, Ric Navarro told OTW, “We are moving toward FDA approval of LOADPRO, the first clinical use of LOADPRO and CE Mark for LOADPRO.

“Surgeons currently assess forces by feel, this will allow them to quantify forces (by way of rod strain) as they do their correction in kyphotic deformities including lumbar flat back. Keeping forces lower while still achieving the desired correction is expected to lead to fewer hardware related complications.

“We are looking to finish out the fundraising round (through September) to enable pursuit of a Humanitarian Device Exemption and a pilot IDE [investigational device exemption] trial in children with scoliosis. Since LOADPRO is very similar in construction to ACCUVISTA we feel it will pave the regulatory pathway through FDA as a Class II device.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy